Connect Biopharma Holdings Limited
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CNTB and other ETFs, options, and stocks.About CNTB
Connect Biopharma Holdings Ltd. operates as clinical-stage biopharmaceutical company. It focuses on advancing rademikibart, an anti-interleukin-4-receptor alpha antibody, to transform acute and chronic care in asthma and chronic obstructive pulmonary disease.
CNTB Key Statistics
Stock Snapshot
With a market cap of 150.48M, Connect Biopharma Holdings Limited(CNTB) trades at $2.38. The stock has a price-to-earnings ratio of -2.39.
On 2026-05-17, Connect Biopharma Holdings Limited(CNTB) stock moved within a range of $2.33 to $2.48. With shares now at $2.38, the stock is trading +2.1% above its intraday low and -4.0% below the session's peak.
Trading volume for Connect Biopharma Holdings Limited(CNTB) stock has reached 114.2K, versus its average volume of 153.22K.
Over the past 52 weeks, Connect Biopharma Holdings Limited(CNTB) stock has traded between a high of $3.82 and a low of $0.72.
Over the past 52 weeks, Connect Biopharma Holdings Limited(CNTB) stock has traded between a high of $3.82 and a low of $0.72.
CNTB News
“We have had a strong start to the year as we continue to build upon the body of preclinical and clinical evidence supporting the potential of rademikibart to t...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.